Florian B Mayr
Florian B Mayr
Verified email at pitt.edu
Title
Cited by
Cited by
Year
Epidemiology of severe sepsis
FB Mayr, S Yende, DC Angus
Virulence 5 (1), 4-11, 2014
11402014
Infection rate and acute organ dysfunction risk as explanations for racial differences in severe sepsis
FB Mayr, S Yende, WT Linde-Zwirble, OM Peck-Palmer, AE Barnato, ...
Jama 303 (24), 2495-2503, 2010
8412010
Interleukin-6 receptor antagonists in critically ill patients with Covid-19.
AC Gordon, PR Mouncey, F Al-Beidh, KM Rowan, AD Nichol, YM Arabi, ...
The New England journal of medicine, 2021
3802021
Effects of carbon monoxide inhalation during experimental endotoxemia in humans
FB Mayr, A Spiel, J Leitner, C Marsik, P Germann, R Ullrich, O Wagner, ...
American journal of respiratory and critical care medicine 171 (4), 354-360, 2005
1992005
Validation of rotation thrombelastography in a model of systemic activation of fibrinolysis and coagulation in humans
AO Spiel, FB Mayr, C Firbas, P Quehenberger, B Jilma
Journal of Thrombosis and Haemostasis 4 (2), 411-416, 2006
1982006
Desmopressin antagonizes the in vitro platelet dysfunction induced by GPIIb/IIIa inhibitors and aspirin
RA Reiter, F Mayr, H Blazicek, E Galehr, P Jilma-Stohlawetz, ...
Blood 102 (13), 4594-4599, 2003
1352003
Risk of cardiovascular events in survivors of severe sepsis
S Yende, W Linde-Zwirble, F Mayr, LA Weissfeld, S Reis, DC Angus
American journal of respiratory and critical care medicine 189 (9), 1065-1074, 2014
1192014
Proportion and cost of unplanned 30-day readmissions after sepsis compared with other medical conditions
FB Mayr, VB Talisa, V Balakumar, CCH Chang, M Fine, S Yende
Jama 317 (5), 530-531, 2017
1152017
Immune checkpoint inhibition in sepsis: a Phase 1b randomized, placebo-controlled, single ascending dose study of anti-PD-L1 (BMS-936559)
RS Hotchkiss, E Colston, S Yende, DC Angus, LL Moldawer, ED Crouser, ...
Critical care medicine 47 (5), 632, 2019
982019
Elevated hemostasis markers after pneumonia increases one-year risk of all-cause and cardiovascular deaths
S Yende, G D'Angelo, F Mayr, JA Kellum, L Weissfeld, AM Kaynar, ...
PLoS One 6 (8), e22847, 2011
942011
The interleukin-6 G (− 174) C promoter polymorphism does not determine plasma interleukin-6 concentrations in experimental endotoxemia in humans
G Endler, C Marsik, C Joukhadar, R Marculescu, F Mayr, C Mannhalter, ...
Clinical chemistry 50 (1), 195-200, 2004
802004
Differences in immune response may explain lower survival among older men with pneumonia
MC Reade, S Yende, G D’Angelo, L Kong, JA Kellum, AE Barnato, ...
Critical care medicine 37 (5), 1655, 2009
752009
Pharmacodynamics of active site‐inhibited factor VIIa in endotoxin‐induced coagulation in humans
B Jilma, C Marsik, F Mayr, MT Graninger, FB Taylor Jr, MC Ribel, ...
Clinical Pharmacology & Therapeutics 72 (4), 403-410, 2002
742002
The aptamer ARC1779 is a potent and specific inhibitor of von Willebrand Factor mediated ex vivo platelet function in acute myocardial infarction
AO Spiel, FB Mayr, N Ladani, PG Wagner, RG Schaub, JC Gilbert, B Jilma
Platelets 20 (5), 334-340, 2009
692009
Endotoxaemia modulates Toll‐like receptors on leucocytes in humans
C Marsik, F Mayr, F Cardona, U Derhaschnig, OF Wagner, B Jilma
British journal of haematology 121 (4), 653-656, 2003
692003
Recombinant human antithrombin inhibits thrombin formation and interleukin 6 release in human endotoxemia
JM Leitner, C Firbas, FB Mayr, RA Reiter, B Steinlechner, B Jilma
Clinical Pharmacology & Therapeutics 79 (1), 23-34, 2006
682006
Hemostasis in cardiac arrest patients treated with mild hypothermia initiated by cold fluids
AO Spiel, A Kliegel, A Janata, T Uray, FB Mayr, AN Laggner, B Jilma, ...
Resuscitation 80 (7), 762-765, 2009
672009
Identification of LIN28B-bound mRNAs reveals features of target recognition and regulation
R Graf, M Munschauer, G Mastrobuoni, F Mayr, U Heinemann, S Kempa, ...
RNA biology 10 (7), 1146-1159, 2013
642013
Do hospitals provide lower quality of care to black patients for pneumonia?
FB Mayr, S Yende, G D'Angelo, AE Barnato, JA Kellum, L Weissfeld, ...
Critical care medicine 38 (3), 759, 2010
622010
Immune checkpoint inhibition in sepsis: a Phase 1b randomized study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of nivolumab
RS Hotchkiss, E Colston, S Yende, ED Crouser, GS Martin, T Albertson, ...
Intensive care medicine 45 (10), 1360-1371, 2019
592019
The system can't perform the operation now. Try again later.
Articles 1–20